Russell Marker and the Origins of Bioidentical Hormones
by Jeffrey Dach MD
Click Here for my previous article, The Safety Of Bioidentical Hormones.
Where do Bioidentical Hormones Come From?
A couple of times a week, I get the question, “Where do hormones comes from ?” Russell E Marker was the Penn State chemist who originated Progesterone and other Bioidentical Hormones from a plant steroid called Diosgenin. (upper left image Russell Marker courtesy of American Chemical_Society)
Who was Russell Marker ?
Russell Marker was a Penn State chemist in 1938 who invented a practical way to mass produce Progesterone, the pregnancy hormone. using a technique known as the Marker degradation process.
Chemistry Professor at Penn State
In 1938, Marker was a chemistry professor at Pennsylvania State College working on plant steroid chemistry. During this time, Marker found a plant steroid from the Dioscorea family called Diosgenin which could be easily converted into the human bioidentical hormone, Progesterone.
Next, Marker needed an economical source of the plant material to isolate the plant steroid called Diosgenin. (upper left image Russell Markerwith plants courtesy of American Chemical_Society )
Finding the Plant Material in Mexico
In November 1941, Marker found what he had been searching for in a botany textbook describing a Dioscorea plant indigenous to Veracruz in Mexico, called Cabeza de Negro. Left image: Diosgenin from Diascorea plant Mexican Yam courtesy of wikimedia commons.
In 1942, Marker then traveled to Mexico where he purchased some of the Dioscorea plant material and started the mass production of the bioidentical hormone, Progesterone.
In 1943, Marker resigned from Penn State University and moved to Mexico to begin mass production of Progesterone and other bioidentical hormones. Marker refused to assign patent rights to anyone, including himself, thus granting free use of his invention to anyone interested.
In early 1944, Syntex was formed in Mexico to manufacture Progesterone from the Diascorea Diosgenin. In May 1945, over a dispute, Marker left Syntex and started a new company, Botanica-mex, near Mexico City which then made several kilos of Progesterone. Botanica-mex folded in March 1946, and was restarted as a new company called Hormonosynth. During this time, the cabeza de negro plant source was replaced by another yam called barbasco, containing 500% more diosgenin. After Marker’s retirement, the company was again reorganized as Diosynth.
(upper image Chemcial Diagram of Marker Degradation courtesy of American Chemical_Society_CNBP_027297 )
Syntex After Marker Leaves – Syntex Prospers
After Marker left Syntex , the company recruited another chemist George Rosenkranz, who began October 1945, and Syntex was again selling progesterone. Rosenkranz extended the process to the production of testosterone and other bioidentical hormones. Rosenkranz built a research program at Syntex, and recruited other Ph.D. chemists including Carl Djerassi and Alejandro Zaffaroni.
Cortisone and the “Pill”
Further research at Syntex led to discovery that this same plant steroid precursor Diosgenin could be converted to cortisone, a powerful anti-inflammatory steroid. The company also worked on the synthetic birth control pill. By the 1950s, Syntex and its competitors were the major supplier of bioidentical hormones to the United States.
Health Benefits of Diosgenin
While using Diosgenin as a precursor to progesterone, Russel Marker had no way of knowing that Diosgenin has its own health benefits. One of which is as a natural anti-cancer drug. Diosgenin also reduces inflammation, serving as an anti-inflammatory drug. Diosgenein also serves as a lipid control drug, with beneficial effects of lipid profiles.
Articles with Related Interest:
The Safety of Bioidentical Hormones
The Importance of Bioidentical Hormones
Bioidentical Hormones Prevent Heart Disease
Bioidentical Hormones Prevent Arthritis
Author: Jeffrey Dach MD
Links and References:
2) http://portal.acs.org/preview/
The following pages commemorate the designation of the “Marker Degradation” and creation of the Mexican steroid hormone industry as an International Historic Chemical Landmark. The designation was conferred by the American Chemical Society and the Sociedad Química de México in ceremonies at The Pennsylvania State University, University Park, Pennsylvania, on October 1, 1999, in Monterrey, Mexico, on October 25, 1999, and in Mexico City, Mexico, on December 2, 1999.
4) http://en.wikipedia.org/wiki/
The Marker degradation is a three-step synthetic route in steroid chemistry developed by American chemist Russell Earl Marker in 1938–40.
5) http://pubs.acs.org/doi/abs/
The Marker semi-synthesis of progesterone from diosgenin. Marker RE, Krueger J (1940). “Sterols. CXII. Sapogenins. XLI. The Preparation of Trillin and its Conversion to Progesterone”. J. Am. Chem. Soc. 62 (12): 3349–3350.
6) http://pabook.libraries.psu.
Road to Hope for Female Infertility: Progesterone
By Stephen T. Spagnol, Spring 2010
7) pdf file:Russell_Marker_Syntex_
THE “MARKER DEGRADATION” AND CREATION OF THE MEXICAN STEROID HORMONE INDUSTRY 1938–1945 AN INTERNATIONAL HISTORIC CHEMICAL LANDMARK UNIVERSITY PARK, PENNSYLVANIA, OCTOBER 1, 1999 , MEXICO CITY, DECEMBER 2, 1999
Jeffrey Dach MD
Offices of Willow Grove
7450 Griffin Road, Suite 190
Davie, Fl 33314
telephone 954-792-4663
www.jeffreydach.com
www.drdach.com
www.bioidenticalhormones101.
www.naturalmedicine101.com
Subscribe to Newsletter
Click Here for: Dr Dach’s Online Store for Pure Encapsulations Supplements
Click Here for: Dr Dach’s Online Store for Nature’s Sunshine Supplements
Web Sites and Discussion Board Links:
jdach1.typepad.com/blog/
disc.yourwebapps.com/Indices/
disc.yourwebapps.com/Indices/
disc.yourwebapps.com/Indices/
disc.yourwebapps.com/Indices/
disc.yourwebapps.com/Indices/
disc.yourwebapps.com/Indices/
health-forums.1
health-forums.2
Disclaimer click here: www.drdach.com/wst_page20.html
The reader is advised to discuss the comments on these pages with his/her personal physicians and to only act upon the advice of his/her personal physician. Also note that concerning an answer which appears as an electronically posted question, I am NOT creating a physician — patient relationship. Although identities will remain confidential as much as possible, as I can not control the media, I can not take responsibility for any breaches of confidentiality that may occur.
Link to this article: http://wp.me/p3gFbV-o8
Copyright (c) 2013 Jeffrey Dach MD All Rights Reserved. This article may be reproduced on the internet without permission, provided there is a link to this page and proper credit is given.
FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
Leave a Comment
You must be logged in to post a comment.